Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

43.74
Delayed Data
As of 4:02pm ET
 -0.11 / -0.25%
Today’s Change
43.35
Today|||52-Week Range
59.00
-24.69%
Year-to-Date

Today’s Trading

Previous close43.85
Today’s open43.92
Day’s range43.44 - 43.97
Volume2,916,074
Average volume (3 months)2,255,704
Market cap$86.0B
Dividend yield2.07%
Data as of 4:02pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.70%
Revenue growth (last year)+1.43%
P/E ratio3.1
Price/Sales9.38
Price/Book16.34

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.21+0.62%
CELGCelgene-1.57-1.46%
LLYEli Lilly and Co-0.17-0.21%
BMYBristol-Myers Squibb-0.65-1.17%
Data as of 4:02pm ET, 09/28/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Search for Jobs